We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Healthcare Mutual Funds to Buy for Stable Returns
Read MoreHide Full Article
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Franklin Strategic Biotechnology Discovery Fund invests most of its net assets in equity securitiesof biotechnology companies and discovery research firms. FBDIX advisors may also invest a small portion of its net assets in equity or debt securities of any type of issuer.
Franklin Strategic Biotechnology Discovery Fund has three-year annualized returns of 20.9%. As of the end of July 2025, FBDIX held 77 issues, with 7.5% of its assets invested in Gilead Sciences.
Fidelity Select Biotechnology fund invests most of its net assets in common stocks of foreign and domestic companies principally engaged in the research, development, manufacture and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology. FBIOX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Select Biotechnology fund has three-year annualized returns of 15.1%. FBIOX has an expense ratio of 0.63%.
Fidelity Advisor Health Care Fund invests the majority of its net assets in common stocks of foreign and domestic companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. FACTX advisors choose to invest in stocks based on fundamental analysis factors such as the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Advisor Health Care Fund has five-year annualized returns of 5.6%. Edward Yoon has been the fund manager of FACTX since October 2008.
Image: Bigstock
3 Top-Ranked Healthcare Mutual Funds to Buy for Stable Returns
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three healthcare mutual funds, namely Franklin Strategic Biotechnology Discovery Fund (FBDIX - Free Report) , Fidelity Select Biotechnology (FBIOX - Free Report) and Fidelity Advisor Health Care Fund (FACTX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Franklin Strategic Biotechnology Discovery Fund invests most of its net assets in equity securitiesof biotechnology companies and discovery research firms. FBDIX advisors may also invest a small portion of its net assets in equity or debt securities of any type of issuer.
Franklin Strategic Biotechnology Discovery Fund has three-year annualized returns of 20.9%. As of the end of July 2025, FBDIX held 77 issues, with 7.5% of its assets invested in Gilead Sciences.
Fidelity Select Biotechnology fund invests most of its net assets in common stocks of foreign and domestic companies principally engaged in the research, development, manufacture and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology. FBIOX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Select Biotechnology fund has three-year annualized returns of 15.1%. FBIOX has an expense ratio of 0.63%.
Fidelity Advisor Health Care Fund invests the majority of its net assets in common stocks of foreign and domestic companies that are engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. FACTX advisors choose to invest in stocks based on fundamental analysis factors such as the issuer's financial condition, industry position, as well as market and economic conditions.
Fidelity Advisor Health Care Fund has five-year annualized returns of 5.6%. Edward Yoon has been the fund manager of FACTX since October 2008.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>